Search result for 'jb chemicals'

JB Pharma reports Q2 net profit of Rs 208 crore, a 19% increase YoY. Revenue rises to Rs 1,085 crore. Domestic & International business growth detailed.

Indian pharma and healthcare sector saw USD 3.5 billion in deals in Q3 2025, says Grant Thornton Bharat. M&A surged, PE focused on health tech.

CCI approves Torrent Pharma''s acquisition of JB Chemicals stake after modifications. Deal to create India''s second-largest pharma firm.

JB Chemicals & Pharmaceuticals Ltd reported a 14% rise in net profit to Rs 202 crore in Q1, driven by domestic growth and a strong performance in key segments.

Torrent Pharmaceuticals seeks CCI approval for a Rs 19,500 crore deal to acquire a majority stake in JB Chemicals & Pharmaceuticals, making it India's second-largest pharma company.

Torrent Pharmaceuticals' Rs 19,500 crore acquisition of JB Chemicals is expected to complete in 15-18 months, pending regulatory approvals. The deal will strengthen Torrent's market share and...

J B Chemicals stock falls over 7% after Torrent Pharma's acquisition; Torrent Pharma shares rise nearly 4%. Rs 19,500 crore deal makes Torrent India's second-largest pharma company.

Torrent Pharmaceuticals to acquire majority stake in JB Chemicals & Pharmaceuticals for approximately Rs 19,500 crore, making it India's second-largest pharma company.

JB Chemicals & Pharmaceuticals reported a 15% year-on-year increase in consolidated profit after tax to Rs 146 crore in Q4 FY25, driven by strong sales growth. Revenue also rose significantly.

JB Chemicals receives USFDA approval to market a generic hypertension drug, Bisoprolol tablets, in strengths of 5 mg and 10 mg.

Global investment firm KKR has divested a 5.8% stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore through open market transactions. The stake sale was executed through four separate...

JB Chemicals & Pharmaceuticals reported a 21% increase in profit after tax to Rs 162 crore for the third quarter ended December 2024, driven by sales growth across domestic and international...

JB Chemicals & Pharmaceuticals Ltd reported a 16% increase in profit after tax to Rs 175 crore for the second quarter ended September 2024, driven by strong domestic performance and growth in...

JB Chemicals & Pharmaceuticals reported a 25% year-on-year increase in net profit to Rs 177 crore in the first quarter ended June 30, 2024. The company's total income also grew to Rs 1,010 crore...

JB Chemicals & Pharmaceuticals reported a 43% increase in profit after tax (PAT) to Rs 126 crore in the March quarter, driven by strong sales. Revenue also rose to Rs 862 crore.

JB Chemicals & Pharmaceuticals' net profit surged 26% to Rs 134 crore in Q3 FY24, driven by strong domestic performance. Revenue also climbed to Rs 845 crore.

JB Chemicals & Pharmaceuticals Ltd (JB Pharma) has signed an agreement with Novartis for select ophthalmology brands, worth Rs 1,089 crore. The deal includes a trade mark licence agreement and a...